The TLR3 Agonist Inhibit Drug Efflux and Sequentially Consolidates Low-Dose Cisplatin-Based Chemoimmunotherapy while Reducing Side Effects
暂无分享,去创建一个
L. Ding | Q. Hu | Yayi Hou | Jing Ren | Dongya Zhang | Jianjian Ji | Y. Ni | Hui Wang | Xiaofeng Huang | Yi Li